Scientist and angel investor Dr Jay Hetzel has been appointed chairman of UniQuest, The University of Queensland's commercialisation company. [ + ]

Australian scientists have invented a gel that seals wounds and stops bleeding — both internally and externally — within 60 seconds. It sends signals to the body to start repairing the wound — at twice the regular speed. [ + ]

ANSTO and Swedish company Quintus Technologies have formed a new technology partnership that will play a crucial role in treating waste arising from nuclear medicine production. [ + ]

Person-to-person genetic differences may undercut the efficacy of the gene editing process or, in more rare cases, cause a potentially dangerous off-target effect, warn researchers. [ + ]

The overall market value of in vitro diagnostics stands at US$52 billion this year and is projected to grow at a compound annual growth rate of 4.2% to US$69 billion in 2024, according to GlobalData. [ + ]

Researchers, headed by Professor Jens Nielsen at Chalmers University of Technology, have successfully mapped out the complex metabolism of yeast cells. [ + ]

Belgian researchers have labelled the protein Caveolin-1 as a high-potential pursuit in the fight against cancer, describing the 'anti-metastatic surveillance' role of the protein for the first time. [ + ]

You may be impressed to hear that there are iron objects in existence today that date back to the Bronze Age, but their meteorite origin is even more astonishing. [ + ]

Animal studies undertaken at UTHealth have shown that the two seaweed extracts — known as fucoidans — have reduced tumour growth in select cancers and significantly improved the effectiveness of the common chemotherapy drug tamoxifen. [ + ]

A novel compound may restore immune response in patients with melanoma, according to a study presented at the ESMO Immuno Oncology Congress 2017 held in Geneva, Switzerland. [ + ]

Supercomputer simulations have revealed the role of transport proteins called efflux pumps in creating drug resistance in bacteria — a breakthrough that could help improve drugs' effectiveness against life-threatening diseases and restore the efficacy of defunct antibiotics. [ + ]

MGC Pharmaceuticals has executed a binding definitive exclusive supply agreement with pharmaceutical wholesaler HL Pharma to bring its adult epilepsy product, CannEpil, to the Australian market in 2018. [ + ]

The ACCC has instituted proceedings in the Federal Court of Australia against GlaxoSmithKline Healthcare Australia and Novartis Consumer Health Australasia, alleging they made false or misleading representations in the marketing of Voltaren Osteo Gel and Emulgel pain relief products. [ + ]

The National Health and Medical Research Council appears to be getting into the Christmas spirit early, announcing $640m to support Australia's health and medical researchers as well as an initiative to reduce the difference in funded rates between male and female lead investigators. [ + ]

UK researchers have revealed that diabetes and high body-mass index were the cause of 5.6% of new cancer cases worldwide in 2012 — equivalent to 792,600 cases. [ + ]